Navigation Links
Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65
Date:10/13/2008

LOS ANGELES, Oct. 13 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on leading Australian biotechnology company Arana Therapeutics, (ASX: AAH; AIM: AAHx) and raised its target price to AU$1.65. "In our opinion, Arana differentiates itself from many competitors in the biotech space due to a strong cash position, a lucrative recurring revenue stream from IP licenses and a strong internal portfolio of products and proprietary technology platform. We strongly believe that Arana's current product pipeline has significant partnership potential and is bound to attract attention from large pharmaceutical companies. Over the past few years there has been a high level of interest from the large pharmaceutical companies in the human antibody sector, an area where Arana is a leader," said Ross Silver, Director of Research for Vista Partners. For more information and to download the free report, please visit the Vista Partners website at http://www.vistap.com and click on the "download research" icon located in the top right hand corner of the website.

About Vista Partners:

Vista Partners provides independent, equity research to institutional and individual investors, with a focus on publicly traded small capitalization companies. With offices in Los Angeles and San Francisco, Vista Partners is one of the fastest growing independently owned equity research firms. Vista Partners professional staff have backgrounds in finance, corporate communications and investment banking. More information is available at http://www.vistap.com.

About Arana Therapeutics:

Arana Therapeutics (ASX: AAH) is an international biopharmaceutical company formed through the merger of Peptech and EvoGenix in August 2007. The company uses superior technology to develop next generation drugs that will improve the lives of patients with inflammatory
'/>"/>

SOURCE Vista Partners
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
3. Synvista Therapeutics to Present at the BIO InvestorForum 2007
4. Synvista Therapeutics to be Featured on Wallst.net
5. Provista Awards Agreement to Spheris
6. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
7. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
8. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
9. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
10. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
11. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)... - Additional Pipeline Product Agreement Executed ..., , MONTREAL and BAGSVAERD, Denmark, Dec. 3...s Inc. (TSX:CJB) and Novozymes Biopharma UK Ltd., ...today that the Companies have entered into a long-...ovozymes Biopharma will exclusively supply its rec...
(Date:12/3/2008)...N, Ga., Dec. 3 CeloNova BioScience... areas in which it is commercializing the,CATANIA...R)-F -- a stent,system that has not had any stent...and available for purchase throughout Europe and n...world-wide expansion ongoing. Concurrently,CeloN...
(Date:12/3/2008)...GO, Dec. 3 Advanced Life... announced that the U.S. Food and Drug,Administra...w Drug Application,(NDA) for cethromycin, a novel... mild-to-moderate community acquired pneumonia (CA... 10-month review such that the anticipated,target...
(Date:12/3/2008)...ymbol: SBS , , CALGARY, Dec. 3 /PRNewswire-...biotechnology company developing protein pharmaceu... initiated a phase I/II clinical trial of its plan... drug in humans. The trial, taking place in the Un...olunteers in a three-arm study (SBS-1000 insulin a...
Breaking Biology Technology:ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 2ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 3CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 3Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia 2Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia 3SemBioSys begins phase I/II trial of insulin produced in plant seeds 2SemBioSys begins phase I/II trial of insulin produced in plant seeds 3
...er Council APPLETON, Wis. Foreign competition ha...mploy the latest technology and find new marketsor...lines, but it,s a story from 1911. It still serves...e leading newsprint producer in the United States....1 with the lifting of federal tariffs on Canadian ...
...oft BROOKFIELD, Wis. Fiserv Imagesoft , a divis... firm Fiserv, announced on Thursday that it has co...applications. The augmentations are geared specifi...cement documents (IRDs), which are paper copies of...features of ExchangeGuard include the ability to a...
... mission to Japan is building interest in possible...aring his experiences abroad in a conference call ...ing mission with several Wisconsin representatives...s and networking with Japanese business representa...bout the value of Wisconsin and what a good place ...
...f software. The first is that any mildly successfu... delusion it is an operating system. Thats a topic... invent uses for a given piece of software that it...ence with Half.com is a twist on that rule. eBay b...its users into the eBay on-line auction model. A f...
Other Biology Technology:Wisconsin's paper industry needs technology, innovation to prosper. 2Wisconsin's paper industry needs technology, innovation to prosper. 3Doyle builds bridges and hopes for deals in Japan 2Doyle builds bridges and hopes for deals in Japan 3Byron's laws of software 2Byron's laws of software 3
(Date:12/3/2008)...ke University study suggests that evolution can be...gs depend on an energy-efficient style of four-foo...y, cats seem to have evolved a profoundly ineffici...rd in slow motion. , "It is usually assumed that...niel Schmitt, a Duke associate professor of evolut...
(Date:12/3/2008)...act in drug trials that individuals can respond ju...ive drug. On the other hand, it is difficult to e...cebos. A team of researchers from Uppsala Univers...variants that can impact the placebo effect and a ...o respond to placebos. , The study, published in...
(Date:12/3/2008)...ding success of the first tandem mission between E... satellites together again to help improve our und... spacecraft, and Envisat, the largest environmenta...ure Radar (SAR) instruments that provide high reso...ning two or more SAR images of the same site, slig...
(Date:12/3/2008)...take place December 14-17, 2008 at the University,...he auspices of BGU,s Jacob Blaustein Institutes fo...f the conference are the United Nations Educationa...Israel,s Ministry for Foreign Affairs, Jewish Nati...im, the global leader in smart water solutions for...
Breaking Biology News(10 mins):Dogs chase efficiently, but cats skulk counterintuitively 2Genes determine whether sugar pills work 2ESA satellites flying in formation 2Ben-Gurion University of the Negev to host 2NCPA Statement Supporting H R 6331 22535 1NCPA Statement Supporting H R 6331 22535 2American Lung Association Offers Free Assistance for Smokefree Air Act 22529 1American Lung Association Offers Free Assistance for Smokefree Air Act 22529 2Newly approved ocular safety methods reduce animal testing 22528 1Newly approved ocular safety methods reduce animal testing 22528 2Newly approved ocular safety methods reduce animal testing 22528 3Traumatic Brain Injuries Can Result From Senior Falls 22522 1Traumatic Brain Injuries Can Result From Senior Falls 22522 2Traumatic Brain Injuries Can Result From Senior Falls 22522 3
...among the human immune system,s T cells allows the...p into full-blown AIDS. The study, which employs a...ystem evolution, also suggests a new strategy for ... computer simulations suggest may prevent the fina...or publication in Physical Review Letters, is avai...
...ton report a new and efficient strategy, using egg...hat can be transplanted without the risk of reject...pient,s immune system. The findings will be publis..., Though done in mice, the work establishes the pr...customized embryonic stem cells that are genetical...
...a boy is hardwired into fruit fly neurons, accordi...dvance online publication by a research team from ...lar Pathology in Vienna. The results confirm that ...ying sexual differences in behavior. The findings ...or understanding the biology of aggression and how...
...harmaceutical Research & Development (J&JP...w molecular mechanism that may underlie neuropathi...e of chronic neuropathic pain, and the preclinical...apies shown in this research, together present an ...at the severe pain associated with such common con...
Other Biology News:HIV exploits competition among T-cells 2HIV exploits competition among T-cells 3Researchers create genetically matched embryonic stem cells for transplantation 2Researchers create genetically matched embryonic stem cells for transplantation 3Fighting like a girl or boy determined by gene in fruit flies 2Fighting like a girl or boy determined by gene in fruit flies 3 New mechanism underlying pain found 2
...system holds 48 x 0.2 ml tubes, or a 48-well micro...luorescence (470-500 nm) for each well, and a pair...3-543 nm and 540-700 nm). The system is built on a...superb thermal performance. System dimensions are ...
...rain chambers with precise uniaxial mechanical str...t cells grow over long periods of time with regula...ws you to control the frequency and degree of the ...nstrument fits in a standard cell culture incubato...
The Cytomics FC 500 Series is a sophisticated product family equipped with the most advanced technologies available. The FC 500 Series delivers flexible testing, powerful software and a user-friendly
...perior to transfection in some applications. For ...Sin you can study lethal proteins and control the ...se, delivery of blocking antibodies may provide mo...xperiments. ,With PULSin you can target intrace...
Biology Products: